The Effects of Ballet-Based Exercise Training on Respiratory Functions, Balance, Cognitive Functions, Peripheral Muscle Strength, Functional Capacity and Quality of Life in Patients With Parkinson's Disease
1 other identifier
interventional
24
0 countries
N/A
Brief Summary
This study investigates the impact of an 8-week ballet-based dance therapy on people with Parkinson's disease. It aims to assess the effect of ballet on motor and non-motor symptoms, such as balance, cognitive function, functional capacity, and quality of life. The study will provide insights into the potential of ballet therapy as an effective, non-pharmacological treatment for Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2025
CompletedFirst Posted
Study publicly available on registry
May 23, 2025
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
May 23, 2025
May 1, 2025
1.5 years
May 4, 2025
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Functional Capacity
Functional capacity will be assessed using the Six-Minute Walk Test (6MWT) according to American Thoracic Society (ATS) guidelines. The total distance walked will be recorded.
At baseline and at week 9 (after 8 weeks of intervention)
Forced Expiratory Volume in 1 Second (FEV₁)
FEV₁ will be assessed using spirometry and reported in liters (L). FEV1 will be measured according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).
At baseline and at week 9 (after 8 weeks of intervention)
Forced Vital Capacity (FVC)
FVC will be assessed using spirometry and reported in liters (L). FVC will be measured according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).
At baseline and at week 9 (after 8 weeks of intervention)
Tiffeneau Index (FEV₁/FVC Ratio)
The ratio of FEV₁ to FVC will be calculated using spirometry and reported as a percentage (%).
At baseline and at week 9 (after 8 weeks of intervention)
Peak Expiratory Flow (PEF)
PEF will be assessed using spirometry and reported in liters per minute (L/min). PEF will be measured according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).
At baseline and at week 9 (after 8 weeks of intervention)
Forced Expiratory Flow 25-75% (FEF₂₅-₇₅%)
FEF₂₅-₇₅% will be assessed using spirometry and reported in liters per second (L/s). FEF₂₅-₇₅%will be measured according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).
At baseline and at week 9 (after 8 weeks of intervention)
Secondary Outcomes (5)
Respiratory Muscle Strength
At baseline and at week 9 (after 8 weeks of intervention)
Balance
At baseline and at week 9 (after 8 weeks of intervention)
Cognitive Function
At baseline and at week 9 (after 8 weeks of intervention)
Peripheral Muscle Strength
At baseline and at week 9 (after 8 weeks of intervention)
Change in Quality of Life
At baseline and at week 9 (after 8 weeks of intervention)
Study Arms (2)
Ballet-Based Dance Therapy
EXPERIMENTALParticipants in this arm will engage in an 8-week ballet-based dance therapy program, specifically designed to enhance functional capacity, balance, peripheral muscle strength, cognitive function, and overall quality of life. The program will be conducted twice a week, with each session lasting approximately 60 minutes. The dance exercises will be tailored to meet the needs of individuals with Parkinson's disease, focusing on improving motor skills, flexibility, and coordination. The primary goal is to assess the impact of ballet-based exercises on various parameters such as respiratory function, balance, and muscle strength.
Standard Care with Exercise Counseling
ACTIVE COMPARATORParticipants in this arm will continue with their standard medical treatment for Parkinson's disease, including pharmacological management and routine care. Additionally, they will receive a one-time exercise counseling session delivered by a physiotherapist and an informational brochure that includes recommendations for general, unsupervised home-based exercises suitable for Parkinson's patients. No structured or supervised exercise sessions will be provided.
Interventions
An 8-week ballet-based dance therapy program designed to improve balance, flexibility, peripheral muscle strength, cognitive functions, and overall functional capacity in Parkinson's disease patients. The therapy will be conducted twice a week, with each session lasting approximately 60 minutes. The exercises will be adapted to the participants' physical abilities and will focus on enhancing motor coordination, strength, and stability through ballet-inspired movements.
Participants in the control group will receive standard care for Parkinson's disease, including pharmacological management and routine clinical follow-up. Additionally, they will receive a one-time exercise counseling session and an informational brochure outlining general home-based exercises appropriate for individuals with Parkinson's disease. No supervised or structured exercise sessions will be conducted.
Eligibility Criteria
You may qualify if:
- Age 18 years or older.
- Diagnosed with Parkinson's disease.
- Modified Hoehn and Yahr stages I to III.
- Willingness to participate and provide informed consent.
You may not qualify if:
- Joint deformities or severe movement limitations that prevent participation in dance exercises.
- Mental retardation (severe cognitive impairment).
- Major surgery within the past 6 months.
- Presence of uncontrolled cardiovascular, pulmonary, or oncological diseases.
- Diagnosed visual or auditory impairments affecting balance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Podlewska AM, Batzu L, Soukup T, Sevdalis N, Bakolis I, Derbyshire-Fox F, Hartley A, Healey A, Woods A, Crane N, Pariante C, Ray Chaudhuri K. The PD-Ballet study: study protocol for a randomised controlled single-blind hybrid type 2 clinical trial evaluating the effects of ballet dancing on motor and non-motor symptoms in Parkinson's disease. BMC Complement Med Ther. 2024 Jan 17;24(1):41. doi: 10.1186/s12906-023-04296-y.
PMID: 38233784BACKGROUNDMcGill A, Houston S, Lee RYW. Effects of a ballet-based dance intervention on gait variability and balance confidence of people with Parkinson's. Arts Health. 2019 Jun;11(2):133-146. doi: 10.1080/17533015.2018.1443947. Epub 2018 Mar 6.
PMID: 31038440BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 4, 2025
First Posted
May 23, 2025
Study Start
June 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
May 23, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share